Immunohistochemistry in gynecological pathology

Although the majority of diagnoses in gynecological pathology are established on examination of routine hematoxylin and eosin stained sections, additional tests are occasionally required. Immunohistochemistry is widely used to provide additional diagnostic information in problematic cases. This review touches on some of the basics of the procedure, presents an example immunohistochemical panel, and discusses some of the most common immunohistochemical markers used in diagnostic gynecological pathology. Differential diagnostic problems and relevant immunohistochemical stains for the vulva, vagina, cervix, uterus, and ovary are also addressed.

[1]  S. Abbondanzo,et al.  c-Kit (CD117) reactivity in extramedullary myeloid tumor/granulocytic sarcoma. , 2009, Archives of pathology & laboratory medicine.

[2]  R. Broaddus,et al.  Ovarian Sex Cord-Stromal Tumors: An Immunohistochemical Study Including a Comparison of Calretinin and Inhibin , 2003, Modern Pathology.

[3]  L. Sobin,et al.  Expression of cytokeratins 7 and 20 in carcinomas of the gastrointestinal tract , 2003, Histopathology.

[4]  A. Haitel,et al.  p16INK4a Is a Useful Marker for the Diagnosis of Adenocarcinoma of the Cervix Uteri and Its Precursors: An Immunohistochemical Study With Immunocytochemical Correlations , 2003, The American journal of surgical pathology.

[5]  R. Kurman,et al.  Calretinin, a More Sensitive but Less Specific Marker Than &agr;-Inhibin for Ovarian Sex Cord-Stromal Neoplasms: An Immunohistochemical Study of 215 Cases , 2002, The American journal of surgical pathology.

[6]  M. von Knebel Doeberitz,et al.  p16INK4a Immunohistochemistry Improves Interobserver Agreement in the Diagnosis of Cervical Intraepithelial Neoplasia , 2002, The American journal of surgical pathology.

[7]  R. Soslow,et al.  β-Catenin and E-Cadherin Expression Patterns in High-Grade Endometrial Carcinoma Are Associated with Histological Subtype , 2002, Modern Pathology.

[8]  S. Riethdorf,et al.  Human papillomaviruses, expression of p16, and early endocervical glandular neoplasia. , 2002, Human pathology.

[9]  G. Pinkus,et al.  WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids. , 2002, American journal of clinical pathology.

[10]  P. Clement,et al.  An Immunohistochemical Analysis of Endometrial Stromal and Smooth Muscle Tumors of the gUterus: A Study of 54 Cases Emphasizing the Importance of Using a Panel Because of Overlap in Immunoreactivity for Individual Antibodies , 2002, The American journal of surgical pathology.

[11]  N. Goldstein,et al.  WT1 is an integral component of an antibody panel to distinguish pancreaticobiliary and some ovarian epithelial neoplasms. , 2001, American journal of clinical pathology.

[12]  G. Fuller,et al.  Non-Hodgkin's Lymphoma Involving the Gynecologic Tract: A Review of 88 Cases , 2001, Advances in anatomic pathology.

[13]  B. Quade,et al.  Ki-67, Cyclin E, and p16 INK4 Are Complimentary Surrogate Biomarkers for Human Papilloma Virus-Related Cervical Neoplasia , 2001, The American journal of surgical pathology.

[14]  R. Soslow,et al.  h-Caldesmon, a Novel Smooth Muscle-Specific Antibody, Distinguishes Between Cellular Leiomyoma and Endometrial Stromal Sarcoma , 2001, The American journal of surgical pathology.

[15]  P. Chu,et al.  Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases , 2000, Modern Pathology.

[16]  D. Arber,et al.  Paraffin section immunophenotype of cutaneous and extracutaneous mast cell disease: comparison to other hematopoietic neoplasms. , 2000, The American journal of surgical pathology.

[17]  D. Coppola,et al.  Immunohistochemical Profile of Endometrial Adenocarcinoma: A Study of 61 Cases and Review of the Literature , 2000, Modern Pathology.

[18]  I. Konishi,et al.  Immunohistochemical Detection of the Wilms' Tumor Gene (WT1) in Epithelial Ovarian Tumors , 2000, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[19]  W. R. Hart,et al.  Proliferative epidermal lesions associated with anogenital Paget's disease. , 2000, The American journal of surgical pathology.

[20]  N. Ordóñez,et al.  Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma. , 2000, The American journal of surgical pathology.

[21]  P. Chu,et al.  Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. , 2000, American journal of clinical pathology.

[22]  Bin Yang,et al.  Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression. , 2000, The American journal of surgical pathology.

[23]  M. Nucci,et al.  Cellular pseudosarcomatous fibroepithelial stromal polyps of the lower female genital tract: an underrecognized lesion often misdiagnosed as sarcoma. , 2000, The American journal of surgical pathology.

[24]  C. Muller,et al.  Frequent expression of β-human chorionic gonadotropin (β-hCG) in squamous cell carcinoma of the cervix , 1999 .

[25]  K. Mittal Utility of proliferation-associated marker MIB-1 in evaluating lesions of the uterine cervix. , 1999, Advances in anatomic pathology.

[26]  W. Zheng,et al.  p53 immunoreactivity in endometrial metaplasia with dysfunctional uterine bleeding , 1999, Histopathology.

[27]  I. Shih,et al.  Immunohistochemical Localization of Inhibin-α in the Placenta and Gestational Trophoblastic Lesions , 1999 .

[28]  W. R. Hart,et al.  Primary ovarian mucinous cystadenocarcinomas: a clinicopathologic study of 49 cases with long-term follow-up. , 1998, The American journal of surgical pathology.

[29]  M. Nowak,et al.  Perianal Paget's disease: distinguishing primary and secondary lesions using immunohistochemical studies including gross cystic disease fluid protein-15 and cytokeratin 20 expression. , 1998, Archives of pathology & laboratory medicine.

[30]  N. Ordóñez Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas. , 1998, The American journal of surgical pathology.

[31]  M. Dietel,et al.  Utility of 123C3 monoclonal antibody against CD56 (NCAM) for the diagnosis of small cell carcinomas on paraffin sections. , 1997, Human pathology.

[32]  M. Costa,et al.  Inhibin immunohistochemistry applied to ovarian neoplasms: a novel, effective, diagnostic tool. , 1997, Human pathology.

[33]  J. Goldblum,et al.  Vulvar Paget's disease: a clinicopathologic and immunohistochemical study of 19 cases. , 1997, The American journal of surgical pathology.

[34]  D. Page,et al.  Cytokeratins, CEA, and mucin histochemistry in the diagnosis and characterization of extramammary Paget's disease. , 1997, American journal of clinical pathology.

[35]  G. Bratthauer,et al.  Use of monoclonal antibody against human inhibin as a marker for sex cord-stromal tumors of the ovary. , 1997, The American journal of surgical pathology.

[36]  R. Kurman,et al.  Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[37]  A. Sabichi,et al.  Molecular characterization of adenocarcinoma of the cervix. , 1997, Gynecologic oncology.

[38]  C. Gilks,et al.  Radiation-induced atypia of endocervical epithelium: a histological, immunohistochemical and cytometric study. , 1996, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[39]  P. Maxwell,et al.  Monoclonal antibody MIB1 in the assessment of cervical squamous intraepithelial lesions. , 1996, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[40]  D. Dabbs,et al.  The immunohistochemical discrimination of endometrioid adenocarcinomas. , 1996, Human pathology.

[41]  M. Sherman,et al.  p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. , 1995, Human pathology.

[42]  A. Gown,et al.  Paget's disease and melanoma of the vulva. Use of a panel of monoclonal antibodies to identify cell type and to microscopically define adequacy of surgical margins , 1993 .

[43]  J. Quesenberry,et al.  Distribution of CA 125 in adenocarcinomas. An immunohistochemical study of 481 cases. , 1992, American journal of clinical pathology.

[44]  A. Gown,et al.  Paget's disease and melanoma of the vulva. Use of a panel of monoclonal antibodies to identify cell type and to microscopically define adequacy of surgical margins. , 1992, Gynecologic oncology.

[45]  T. Rollason,et al.  Immunohistochemical and electron microscopic findings in benign fibroepithelial vaginal polyps. , 1990, Journal of clinical pathology.

[46]  C. Gilks,et al.  Adenoma Malignum (Minimal Deviation Adenocarcinoma) of the Uterine Cervix: A Clinicopathological and Immunohistochemical Analysis of 26 Cases , 1989, The American journal of surgical pathology.

[47]  N. Ordóñez,et al.  Immunohistochemical differentiation of clear-cell carcinoma of the female genital tract and endodermal sinus tumor with the use of alpha-fetoprotein and Leu-M1. , 1989, American journal of clinical pathology.

[48]  M. Wick,et al.  Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. , 1989, Human pathology.

[49]  S. Hamilton-Dutoit,et al.  Ki-1 (CD30) antigen is regularly expressed by tumor cells of embryonal carcinoma. , 1988, The American journal of pathology.

[50]  B. Scheithauer,et al.  Immunohistochemistry of germ cell and trophoblastic neoplasms , 1988, Cancer.

[51]  M. Wick,et al.  Placental-like alkaline phosphatase reactivity in human tumors: an immunohistochemical study of 520 cases. , 1987, Human pathology.

[52]  K. Geisinger,et al.  Intermediate Filaments in Endometrial and Endocervical Carcinomas: The Diagnostic Utility of Vimentin Patterns , 1986, The American journal of surgical pathology.

[53]  Geisinger Kr,et al.  Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns. , 1986 .

[54]  H. Fox,et al.  An immunohistochemical study of the incidence and significance of human chorionic gonadotrophin synthesis by epithelial ovarian neoplasms. , 1983, Gynecologic oncology.

[55]  D. Haagensen,et al.  Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. , 1983, The American journal of pathology.

[56]  C. Cohen,et al.  Endocervical and endometrial adenocarcinoma: An immunoperoxidase and histochemical study , 1982, The American journal of surgical pathology.

[57]  J. Lindgren,et al.  DISTINCTION BETWEEN ENDOCERVICAL AND ENDOMETRIAL ADENOCARCINOMA WITH IMMUNOPEROXIDASE STAINING OF CARCINOEMBRYONIC ANTIGEN IN ROUTINE HISTOLOGICAL TISSUE SPECIMENS , 1979, The Lancet.

[58]  M. Stoler,et al.  p16 Immunohistochemistry Improves Interobserver Agreement in the Diagnosis of Cervical Intraepithelial Neoplasia , 2002 .

[59]  I. Shih,et al.  The pathology of intermediate trophoblastic tumors and tumor-like lesions. , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[60]  T. Nikaido,et al.  Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas. , 1999, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[61]  雅麗 Expression of steroid receptors Ki-67 and p53 in uterine leiomyosarcomas , 1998 .

[62]  L. Sobin,et al.  Terminology of endocrine tumors of the uterine cervix: results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute. , 1997, Archives of pathology & laboratory medicine.

[63]  Np Wang Coordinate expression of cytokeratin 7 and 20 defines unique subsets of carcinomas , 1995 .

[64]  R. Scully,et al.  Immunocytochemical localization of placental lactogen and chorionic gonadotropin in the normal placenta and trophoblastic tumors, with emphasis on intermediate trophoblast and the placental site trophoblastic tumor. , 1984, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[65]  H. Michael,et al.  Minimal deviation endocervical adenocarcinoma: clinical and histologic features, immunohistochemical staining for carcinoembryonic antigen, and differentiation from confusing benign lesions. , 1984, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.